Cosmos Health (FRA:V67A) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:V67A Cosmos Health Inc FRA:V67A
27 GF Score
Price €0.27
GF Value €0.32
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Cosmos Health Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

FRA:V67A
27GF Score
Cosmos Health Inc FRA:V67A
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cosmos Health (FRA:V67A) Overvalued in 2026?

Based on GuruFocus' analysis, Cosmos Health stock appears to be undervalued. The current stock price of €0.27 is trading 14.6% below its estimated GF Value™ of €0.32. GuruFocus considers Cosmos Health to be Modestly Undervalued.

Key valuation signals for FRA:V67A:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €0.32 vs. price of €0.27 (14.6% below fair value)
  • GF Score™: 27/100 with 6 warning signs

No single metric tells the full story. See the FRA:V67A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cosmos Health Business Description

Other Exchanges COSM:USA
Address 5 Agiou Georgiou Street, Pilea, Thessaloniki, GRC, 55438
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
27GF Score

Get the complete analysis for FRA:V67A

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.27
Price
€0.32
GF Value